Light Meets Precision:
EIC Pathfinder Project SCALPEL Pioneering a Revolutionary Photoimmunotherapy for Cancer
Theo Theodossiou, Project coordinator
In a groundbreaking effort to revolutionise modern oncology, the SCALPEL project launches a Europe wide initiative aimed at redefining cancer treatment by using light to precisely ‘click’ tags to cancer cells, enabling the immune system to recognise and destroy them with unparalleled accuracy. Project coordinator is Theo Theodossiou, head of the Protonics project group at the Department of Radiation Biology at OUH.
The multidisciplinary initiative funded by the European Innovation Council Pathfinder programme under Horizon Europe with a total budget of more than EUR 4 million aims to revolutionise modern oncology offering new hope for millions worldwide.
From major journals, first or last author from the Institute for Cancer Research
Bergholtz H, Norum JH, Lien TG, Skrede ML, Garred Ø, Sørlie T(2025) B cells and energy metabolism in HER2-positive DCIS: insights into breast cancer progression from spatial-omics analyses Breast Cancer Res, 27(1), 44 DOI 10.1186/s13058-025-01990-2, PubMed 40119362
Tanoli Z, Fernández-Torras A, Özcan UO, Kushnir A, Nader KM, Gadiya Y, Fiorenza L, Ianevski A, Vähä-Koskela M, Miihkinen M, Seemab U, Leinonen H, Seashore-Ludlow B, Tampere M, Kalman A, Ballante F, Benfenati E, Saunders G, Potdar S, Gómez García I, García-Serna R, Talarico C, Beccari AR, Schaal W, Polo Aet al.(2025) Computational drug repurposing: approaches, evaluation of in silico resources and case studies Nat Rev Drug Discov(in press) DOI 10.1038/s41573-025-01164-x, PubMed 40102635
Skotland T, Ekroos K, Llorente A, Sandvig K(2025) Quantitative Lipid Analysis of Extracellular Vesicle Preparations: A Perspective J Extracell Vesicles, 14(3), e70049 DOI 10.1002/jev2.70049, PubMed 40091364
Pallarès-Sastre M, Amayra I, Pulido R, Nunes-Xavier CE, Bañuelos S, Cavaliere F, García M(2025) Cognitive and Adaptive Functioning of CTNNB1 Syndrome Patients: A Comparison With Autism Spectrum Disorder and Cerebral Palsy J Intellect Disabil Res(in press) DOI 10.1111/jir.13235, PubMed 40145647
Naolou T, Schadzek N, Hornbostel JM, Pepelanova I, Frommer M, Lötz F, Sauheitl L, Dultz S, Felde VJMNL, Myklebost O, Lee-Thedieck C(2025) Enhanced gelatin methacryloyl nanohydroxyapatite hydrogel for high-fidelity 3D printing of bone tissue engineering scaffolds Biofabrication, 17(2) DOI 10.1088/1758-5090/adbb90, PubMed 40020249
Yip D, Zalcberg J, Blay JY, Eriksson M, Espinoza D, Price T, Marreaud S, Italiano A, Steeghs N, Boye K, Underhill C, Gebski V, Simes J, Gelderblom H, Joensuu H(2025) Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor: The AGITG ALT-GIST intergroup randomized phase II trial Br J Cancer(in press) DOI 10.1038/s41416-025-02983-w, PubMed 40133509